{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T14:44:07Z","timestamp":1792680247460,"version":"4.5.0"},"reference-count":42,"publisher":"Bentham Science Publishers Ltd.","issue":"1","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDRR"],"published-print":{"date-parts":[[2026,2]]},"abstract":"<jats:sec>\n                    <jats:title>Introduction:<\/jats:title>\n                    <jats:p>A lung condition in which the passage of air into the lungs is obstructed,\nis treated using a combination pharmaceutical aerosol (Pressurised Metered dosage Inhaler)\ndosage form, such as Levosalbutamol Sulphate (LS) and Ipratropium Bromide (IB) pressurized\ninhalation solution, which contains 50 \u03bcg and 20 \u03bcg, respectively. Aerodynamic particle size\ndistribution (APSD) aids in comprehending the likelihood of particle deposition in the lungs. In\naddition to being crucial for the efficacy and safety of medications, the respirable fraction is a\nsignificant critical quality attribute (CQA) for nasal and orally inhaled medicinal formulations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Aim:<\/jats:title>\n                    <jats:p>The evaluation of in-vitro respirable fraction utilizing Next Generator Impactor (NGI)\nsimulates drug particle deposition in the patient's lungs. The current study used a sensitive highpressure\nliquid chromatography technique to assess the deposited respirable fraction through\nAPSD from NGI, as aerodynamic properties of the delivered dosage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods:<\/jats:title>\n                    <jats:p>The samples are subjected to NGI and analyzed on an X-bridge C18\n(50 x 4.6), 3.5 \u03bcm with 35\u00b0C column oven, volume of injection 100 \u03bcL, and 0.5 mL per min\nflow rate using a mobile phase that is a 75:25% v\/v combination of Heptane sulphonic acid sodium\nsalt buffer and Acetonitrile in high-pressure liquid chromatography. The designed approach\nwas validated for its anticipated function and determined the respirable fraction of the\ndelivered dose.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>The respirable fraction (fine particle dose) in \u03bcg for Levosalbutamol sulfate and\nIpratropium bromide were observed 27.644 \u00b1 1.9 and 11.045 \u00b1 1.8, respectively. The fine particle\nfraction in percentage for Levosalbutamol sulfate and Ipratropium bromide were observed\n55 \u00b1 1.8 and 56 \u00b1 1.8, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The reliable results generated by novel combined in-vitro evaluation of LS and IB\nrespirable fractions - correspond to lung deposition in a clinical study, which is about \u2264 5\u03bcm\nparticle size in given doses of LS and IB inhalers.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0125899775352741250309005146","type":"journal-article","created":{"date-parts":[[2025,3,20]],"date-time":"2025-03-20T02:31:15Z","timestamp":1742437875000},"page":"137-146","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of Respirable Fraction by using Next Generation Impactor of Levosalbutamol Sulphate and Ipratropium bromide Metered Dose Inhaler"],"prefix":"10.2174","volume":"18","author":[{"given":"Chirag","family":"Chilka","sequence":"first","affiliation":[{"name":"Bio-Research and Characteristic Center, School of Science, RK University, Rajkot, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2594-1590","authenticated-orcid":true,"given":"Jayesh","family":"Dhalani","sequence":"additional","affiliation":[{"name":"Bio-Research and Characteristic Center, School of Science, RK University, Rajkot, Gujarat, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"78","DOI":"10.3390\/pharmaceutics12010078","volume":"12","author":"Zhang R.","year":"2020","unstructured":"Zhang R.; Hu J.; Deng L.; Aerosol characteristics and Physico-Chemical compatibility of Combivent\u00ae (Containing Salbutamol and Ipratropium bromide) mixed with three other inhalants: Budesonide, beclomethasone or N-Acetylcysteine. Pharmaceutics  2020,12(1),78","journal-title":"Pharmaceutics"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.coph.2017.07.015","volume":"36","author":"de Kruijf W.","year":"2017","unstructured":"de Kruijf W.; Ehrhardt C.; Inhalation delivery of complex drugs \u2014 The next steps. Curr Opin Pharmacol  2017,36,52-57","journal-title":"Curr Opin Pharmacol"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"647","DOI":"10.4155\/tde-2017-0037","volume":"8","author":"Newman S.P.","year":"2017","unstructured":"Newman S.P.; Drug delivery to the lungs: Challenges and opportunities. Ther Deliv  2017,8(8),647-661","journal-title":"Ther Deliv"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"2831","DOI":"10.1007\/s11095-022-03286-y","volume":"39","author":"Kumar R.","year":"2022","unstructured":"Kumar R.; Mehta P.; Shankar K.R.; Nanotechnology-assisted metered-dose inhalers (MDIs) for high-performance pulmonary drug delivery applications. Pharm Res  2022,39(11),2831-2855","journal-title":"Pharm Res"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1080\/17476348.2017.1289843","volume":"11","author":"Ari A.","year":"2017","unstructured":"Ari A.; Fink J.B.; Inhalation therapy in patients with tracheostomy: A guide to clinicians. Expert Rev Respir Med  2017,11(3),201-208","journal-title":"Expert Rev Respir Med"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"61","DOI":"10.3390\/ph15010061","volume":"15","author":"Talaat M.","year":"2022","unstructured":"Talaat M.; Si X.; Xi J.; Effect of MDI actuation timing on inhalation dosimetry in a human respiratory tract model. Pharmaceuticals (Basel)  2022,15(1),61","journal-title":"Pharmaceuticals (Basel)"},{"key":"ref=7","year":"2017","unstructured":"Levosalbutamol: Uses, Interactions, Mechanism of action.  Available from:  https:\/\/go.drugbank.com\/drugs\/DB131392017"},{"key":"ref=8","first-page":"p. 2433","year":"2018","unstructured":"Levosalbutamol sulphate, Indian Pharmacopoeia. 8th ed. Gaziabad:\nIndian Pharmacopoeia Commission  2018,p. 2433"},{"key":"ref=9","year":"2017","unstructured":"Ipratropium: Uses, Interactions, Mechanism of action.   Available from:   https:\/\/go.drugbank.com\/drugs\/DB003322017"},{"key":"ref=10","first-page":"p. 2305","year":"2018","unstructured":"Ipratropium bromide, Indian Pharmacopoeia. 8th ed. Gaziabad:\nIndian Pharmacopoeia Commission  2018,p. 2305"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"720","DOI":"10.1007\/s11094-022-02700-4","volume":"56","author":"Gondhale P.S.","year":"2022","unstructured":"Gondhale P.S.; Deshmukh M.J.; Omase R.V.; Comparative evaluation of fine particle fraction and T2 fraction by using next generation impactor (NGI) and glass twin impinger (GTI) on formoterol fumarate and tiotropium dry powder inhaler (DPI) marketed products. Pharm Chem J  2022,56(5),720-726","journal-title":"Pharm Chem J"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"e0237620","DOI":"10.1371\/journal.pone.0237620","volume":"16","author":"Xu H.","year":"2021","unstructured":"Xu H.; Tong L.; Gao P.; Combination of ipratropium bromide and salbutamol in children and adolescents with asthma: A meta-analysis. PLoS One  2021,16(2),e0237620","journal-title":"PLoS One"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/ppul.24244","volume":"54","author":"Iramain R.","year":"2019","unstructured":"Iramain R.; Castro-Rodriguez J.A.; Jara A.; Salbutamol and ipratropium by inhaler is superior to nebulizer in children with severe acute asthma exacerbation: Randomized clinical trial. Pediatr Pulmonol  2019,54(4),372-377","journal-title":"Pediatr Pulmonol"},{"key":"ref=14","first-page":"pp. 1","volume":"48","year":"2021","unstructured":"USP 44 and NF 39. United State pharmacopoeia commission  2021,48,pp. 1-24"},{"key":"ref=15","year":"2017","unstructured":"European pharmacopoeia  2017","journal-title":"European pharmacopoeia"},{"key":"ref=16","first-page":"pp. 1121-3","volume":"1","year":"2020","unstructured":"Stationary Office Books. United Kingdom:   British Pharmacopoeia Commission  2020,1,pp. 1121-3","journal-title":"British Pharmacopoeia Commission"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"70","DOI":"10.53879\/id.57.02.11701","volume":"57","author":"Bansode A.","year":"2020","unstructured":"Bansode A.; Patil R.; Gaikwad S.; Shetti P.; Development and validation of stability indicating method for Ipratropium bromide by using RP-HPLC. INDIAN DRUGS  2020,57(2),70-72","journal-title":"INDIAN DRUGS"},{"key":"ref=18","doi-asserted-by":"publisher","DOI":"10.1186\/s43094-021-00247-x","volume":"7","author":"Musmade B.","year":"2021","unstructured":"Musmade B.; Sanatan P.; Lokhande S.; Kulkarni S.; Bhope S.; Padmanabhan S.; Development and validation of stability-indicating RP-HPLC method for the simultaneous estimation of Xylometazoline hydrochloride and Ipratropium bromide from nasal spray dosage form. Future J Pharm Sci  2021,7(1)","journal-title":"Future J Pharm Sci"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"16587","DOI":"10.1038\/s41598-023-42766-y","volume":"13","author":"Almalki A.H.","year":"2023","unstructured":"Almalki A.H.; Ramzy S.; Almrasy A.A.; Development and validation of analytical methods for selective determination of albuterol and budesonide in Airsupra inhalation aerosol using spectrophotometry. Sci Rep  2023,13(1),16587","journal-title":"Sci Rep"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"368","DOI":"10.3390\/separations10070368","volume":"10","author":"Harps L.C.","year":"2023","unstructured":"Harps L.C.; Bizjak D.A.; Girreser U.; Quantitation of formoterol, salbutamol, and salbutamol-4\u2032-o-sulfate in human urine and serum via UHPLC-MS\/MS. Separations  2023,10(7),368","journal-title":"Separations"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1055\/a-2007-1820","volume":"73","author":"Haihua G.","year":"2023","unstructured":"Haihua G.; Rui Z.; Liangjun D.; Meng L.; Sha L.; Suqing Z.; HPLC-UV\/VIS for determination of ipratropium bromide mixed with salbuterol, beclomethasone propionate and budesonide using dual wavelength-detection method. Drug Res  2023,73(6),335-340","journal-title":"Drug Res"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3390\/pharmaceutics12080776","volume":"12","author":"Chen Y.","year":"2020","unstructured":"Chen Y.; Du S.; Zhang Z.; Compatible stability and aerosol characteristics of atrovent\u00ae (Ipratropium Bromide) mixed with salbutamol sulfate, terbutaline sulfate, budesonide, and acetylcysteine. Pharmaceutics  2020,12(8),776","journal-title":"Pharmaceutics"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1843","DOI":"10.35629\/7781-070418431850","volume":"7","author":"Gaikwad S.","year":"2022","unstructured":"Gaikwad S.; Shinde M.; Patil M.; Adat P.; Analytical method development and validation of uv spectrophotometric method for simultaneous estimation of ipratropium bromide and levosalbutamol in combined respule formulation. Int J Pharm Res Appl  2022,7(4),1843-1850","journal-title":"Int J Pharm Res Appl"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"131","DOI":"10.7324\/japs.2020.10815","volume":"10","author":"Raj S.","year":"2020","unstructured":"Raj S.; Jamakandi V.; Jalalpure S.; Ronad P.; Simultaneous detection and quantification of bronchodilators in pure form and from in-vitro drug release of a novel combinational formulation. J Appl Pharm Sci  2020,10(8),131-138","journal-title":"J Appl Pharm Sci"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"20210111","DOI":"10.1002\/EXP.20210111","volume":"3","author":"Tong F.","year":"2023","unstructured":"Tong F.; Zhou Y.; Xu Y.; Supramolecular nanomedicines based on host\u2013guest interactions of cyclodextrins. Exploration  2023,3(4),20210111","journal-title":"Exploration"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"108740","DOI":"10.1016\/j.cclet.2023.108740","volume":"35","author":"Yang W.","year":"2024","unstructured":"Yang W.; Zhang W.; Chen J.; Zhou J.; Mono-functionalized pillar[n]arenes: Syntheses, host\u2013guest properties and applications. Chin Chem Lett  2024,35(1),108740","journal-title":"Chin Chem Lett"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"2304249","DOI":"10.1002\/adma.202304249","volume":"36","author":"Yan M.","year":"2024","unstructured":"Yan M.; Wu S.; Wang Y.; Recent progress of supramolecular chemotherapy based on Host\u2013Guest interactions. Adv Mater  2024,36(21),2304249","journal-title":"Adv Mater"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"20220064","DOI":"10.1002\/VIW.20220064","volume":"4","author":"Liu L.","year":"2023","unstructured":"Liu L.; Xiong M.; Rong Q.; Zhang M.; Zhang X.B.; Nucleic acid sensors in vivo: Challenges and opportunities. VIEW  2023,4(3),20220064","journal-title":"VIEW"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"6075","DOI":"10.1039\/D2CS00856D","volume":"52","author":"Yan M.","year":"2023","unstructured":"Yan M.; Wang Y.; Chen J.; Zhou J.; Potential of nonporous adaptive crystals for hydrocarbon separation. Chem Soc Rev  2023,52(17),6075-6119","journal-title":"Chem Soc Rev"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1038\/s41467-024-45592-6","volume":"15","author":"Chen J.","year":"2024","unstructured":"Chen J.; Zhang W.; Yang W.; Separation of benzene and toluene associated with vapochromic behaviors by hybrid[4]arene-based co-crystals. Nat Commun  2024,15(1),1260","journal-title":"Nat Commun"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"216054","DOI":"10.1016\/j.ccr.2024.216054","volume":"517","author":"Dai Y.","year":"2024","unstructured":"Dai Y.; Sun J.; Zhang X.; Supramolecular assembly boosting the phototherapy performances of BODIPYs. Coord Chem Rev  2024,517,216054","journal-title":"Coord Chem Rev"},{"key":"ref=32","year":"1994","unstructured":"Q2A and Q2B, Text on Validation of Analytical Procedures and\nValidation of Analytical Procedures: Methodology. International\nConference on Harmonization. Geneva,  1994"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"37","DOI":"10.2174\/0115734129283491240103071614","volume":"20","author":"Handa U.","year":"2024","unstructured":"Handa U.; Malik A.; Guarve K.; Jan F.; Nagpal K.; Isocratic RP-HPLC method development, validation, and optimization of BCS-II in bulk and dosage form. Curr Pharm Anal  2024,20(1),37-45","journal-title":"Curr Pharm Anal"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.31788\/RJC.2023.1638443","volume":"16","author":"Shah N.T.","year":"2023","unstructured":"Shah N.T.; Dhalani N.J.; Determination of four novel process-related genotoxic impurities in Olmesartan medoxomil tablet by RP-HPLC. Rasayan J Chem  2023,16(3),1543-1552","journal-title":"Rasayan J Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"640","DOI":"10.2174\/1573412915666190222161942","volume":"15","author":"Qiu H.","year":"2019","unstructured":"Qiu H.; Yu C.; Cheng Y.; Simultaneous determination of koumine and gelsemine in human plasma using HPLC-UV assay and its clinical application. Curr Pharm Anal  2019,15(6),640-649","journal-title":"Curr Pharm Anal"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"212","DOI":"10.2174\/0115734129300296240416070559","volume":"20","author":"Rao P.V.","year":"2024","unstructured":"Rao P.V.; Rao N.S.; Sahoo B.M.; Babu N.R.; Rapid development and validation of atoltivimab, maftivimab and odesivimab in pharmaceutical dosage form by using the rp-hplc method. Curr Pharm Anal  2024,20(3),212-223","journal-title":"Curr Pharm Anal"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"579","DOI":"10.31788\/RJC.2023.1628212","volume":"16","author":"Panchal J.","year":"2023","unstructured":"Panchal J.; Dhaduk B.; Dhalani J.; Stability indicating isocratic RP-HPLC and second derivative UV spectroscopic methods for simultaneous determination of Remogliflozin etabonate and Vildagliptin hydrochloride. Rasayan J Chem  2023,16(2),579-587","journal-title":"Rasayan J Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.14233\/ajchem.2023.27910","volume":"35","author":"Panchal J.","year":"2023","unstructured":"Panchal J.; Dhalani J.; Novel ultra-fast liquid chromatography method for simultaneous quantification of metformin hydrochloride and Remogliflozin etabonate. Asian J Chem  2023,35(9),2055-2060","journal-title":"Asian J Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"100779","DOI":"10.1016\/j.rechem.2023.100779","volume":"5","author":"Singh R.","year":"2023","unstructured":"Singh R.; Dhaduk B.; Dhalani J.; A rapid quantification method for simultaneous determination of pendimethalin and metribuzin contents in suspoemulsion formulation. Results in Chemistry  2023,5,100779","journal-title":"Results in Chemistry"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"2154","DOI":"10.31788\/RJC.2023.1648441","volume":"16","author":"Singh R.","year":"2023","unstructured":"Singh R.; Dhalani J.; A simple and quick run time RP-HPLC technique for combined analysis of Sulfentrazone and Clomazone herbicides. Rasayan J Chem  2023,16(04),2154-2162","journal-title":"Rasayan J Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"47","DOI":"10.56042\/ijct.v31i3.4234","volume":"31","author":"Shah T.","year":"2024","unstructured":"Shah T.; Kapadiya K.; Dhalani J.; Isolation, characterization and cumulative quantification approach for nine organic impurities in empagliflozin and linagliptin drugs. Indian J Chem Technol  2024,31,47-82","journal-title":"Indian J Chem Technol"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1093\/chromsci\/bmac016","volume":"61","author":"Dewani A.P.","year":"2023","unstructured":"Dewani A.P.; Vekariya H.J.; Optimization of high-performance liquid chromatographic method using central composite design for the simultaneous estimation of ciprofloxacin and loteprednol. J Chromatogr Sci  2023,61(3),279-287","journal-title":"J Chromatogr Sci"}],"container-title":["Current Drug Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0125899775352741250309005146","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/240386\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0125899775352741250309005146","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T06:05:23Z","timestamp":1772085923000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/240386\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0125899775352741250309005146","relation":{},"ISSN":["2589-9775"],"issn-type":[{"value":"2589-9775","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-09-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-20","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-01-29","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-02-04","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}